End to end lung nodule management
33%
Increment in inter-reader agreement on Chest CTs
6.6%
Increased sensitivity on CTs; <1 FPs per scan
46%
Reduction in time spent per CT
0.94
AUC (CXRs) in finding potential malignancies
300k+
CXRs processed via Incidental Detection pathways; 1100+ sites
7.4%
CXRs flagged with potential malignancy risk; 27% of these had high-risk scores
qXR
World's most widely used AI for comprehensive chest X-ray reporting, providing pre-read assistance in <1 minute with detailed lung findings.
Identifymore incidental nodules from CXRs taken from non-oncology departments and help early-stage lung cancer detection
Generate patented and clinically validated Lung Nodule Malignancy (LNM) Risk Score for nodules detected to reduce false positives
Provide insights into nodule characteristics to increase confidence and accuracy for clinicians
Setup Automated Discordance framework for uninterrupted workflow, still helping find more cases
SetupAutomated Discordance framework for uninterrupted workflow, still helping find more cases
Qure app
Helps in early detection and monitoring of lung nodules. Precise quantification, comprehensive characterization, and 3D visualization ensure no missed opportunities for early intervention.
Locate nodules via incidental and targeted screening
Measure volume with just 1 click
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
“qXR has resulted in a 30% reduction in reporting time for our Radiologists.”
Dr. Shibu Vijayan
Global Director TB/HIV,
PATH
Needle in Haystack: Opportunistic Screening of Lung Nodules amidst COVID-19 using Deep Learning
Author Names, Author Names
Needle in Haystack: Opportunistic Screening of Lung Nodules amidst COVID-19 using Deep Learning
xyz
